Antidepressant Use During Pregnancy Does Not Affect Child Development

FEBRUARY 01, 2003

Use of antidepressants during pregnancy does not affect child development, according to a prospective study published in the American Journal of Psychiatry.

Researchers compared mother?child pairs who were exposed to tricyclic antidepres-sants (n = 46) or fluoxetine (n = 40) during gestation with an unexposed, nonde-pressed control group (n = 36). Neither tricyclic antidepressants nor fluoxetine affected the child?s global IQ, language development, or behavior.

Instead, the mothers? depression was associated with impaired cognitive and language achievement among their children.



SHARE THIS SHARE THIS
0

Become A RESPIMAT T.O.P. Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?


Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.